PATENT CLAIM ANALYSIS

Application Number: 16343157
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-10
Patent Classification: ["514", "169000"]

Abstract:
Disclosed are methods of treating or reducing the occurrence of a steatohepatitis disorder. The disorder may include, for example, NASH, parenteral nutrition associated liver disease (PNALD), or genetic forms of liver disease. The method may comprise the step of administering a composition comprising obeticholic acid to an individual in need thereof.

Claim (Index 4):
The method of  claim 1  wherein said composition comprises a buffer.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 100.0
- Lexical Diversity: 1.36364
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12692468', '12817084', '13315220', '11673411', '12913660']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.730138494389096
- 35 USC 102 Novelty (BERT): 0.5203337803014721
- Combined Prediction Score: 0.7091580229803336
- Mean Citation Score: 96.9224474
- Max Citation Score: 98.00142
- Similarity Product: 42.57558959181726

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test